Genesis Medical Scheme submitted annual financial statements for 2012 to the Registrar of Medical Schemes. The Registrar rejected these statements on the basis that they did not correctly reflect Genesis's financial position. The rejection was based primarily on the High Court judgment in Registrar of Medical Schemes v Ledwaba NO (Omnihealth case), which held that Personal Medical Savings Account (PMSA) funds constitute trust property under the Financial Institutions (Protection of Funds) Act 28 of 2001. The Registrar had issued circulars (38 of 2011, 5 of 2012, and 41 of 2012) following Omnihealth, requiring medical schemes to reflect PMSA funds as trust property. Genesis's financial statements reflected PMSA funds as its assets and appropriated the interest earned on these funds to itself. The Registrar rejected the statements because: (a) Genesis incorrectly reflected PMSA funds as assets; (b) Genesis understated its liabilities by excluding PMSA balances and interest; and (c) the auditor's assurance report omitted prescribed paragraphs 13, 14, and 15. Genesis brought a review application under PAJA on the sole ground that the Registrar's decision was materially influenced by an error of law, specifically that Omnihealth was wrongly decided.
Leave to appeal granted. Appeal upheld. The order of the Supreme Court of Appeal set aside and substituted with an order dismissing the appeal with costs, including costs of two counsel. The respondents ordered to pay the applicant's costs in the Constitutional Court, including where applicable the costs of two counsel. This effectively restored the High Court's decision setting aside the Registrar's rejection of Genesis's financial statements.
The binding legal principles established are: (1) Medical schemes are not trustees of PMSA funds but hold them as their own assets subject to contractual obligations to members; (2) The relationship between a medical scheme and its members is fundamentally commercial and contractual, not fiduciary, as evidenced by the MSA's definition of "business of a medical scheme" which contemplates undertaking liability in return for premiums/contributions; (3) When member contributions (including PMSA allocations) enter a medical scheme's bank account under section 26(1)(c), they become assets of the scheme, not trust property; (4) Section 35(9)(c)'s requirement that PMSAs be reflected as liabilities presupposes they are also assets - the solvency margin requirement in section 35(3) (assets must exceed liabilities) would otherwise be impossible to satisfy without finding additional external assets; (5) A medical scheme may retain interest earned on PMSA funds as part of the commercial quid pro quo for providing members with advance access to their annual PMSA allocation; (6) Administrative instruments (circulars, regulations) that derive their entire legal force from a judicial decision or statute fall when that foundation is removed, without requiring separate setting aside - the principle is analogous to regulations falling when the enabling Act is declared invalid; (7) For a review ground under PAJA section 6(2)(d), an applicant must prove both the existence of an error of law and that the error materially influenced the decision; (8) Sections 37 and 38 of the MSA must be read as an integrated whole - section 37 empowers the Registrar to determine the form of financial statements, while section 38 provides the enforcement mechanism through rejection powers.
The majority judgment made several non-binding observations: (1) Nothing in the MSA prevents a particular medical scheme from agreeing with its members that it holds specified funds in trust - such an arrangement would be subject to Registrar approval under section 33 and would create a genuine trust relationship governed by the FIA; (2) If Genesis's rules (which state PMSAs "remain the property of the member") create a trust relationship, Genesis may be required to open separate bank accounts and comply with FIA accounting provisions, with possible protection from creditors on insolvency - but this was not the issue before the Court; (3) The minority's concern about protecting poorer members was misconceived - members who choose PMSA options have disposable income for saving, placing them in a "missing middle" category rather than among the poorest who cannot afford any savings; (4) The Court noted but did not decide the practical implications for medical scheme insolvency - what happens to PMSA funds if a scheme becomes insolvent was described as the question "lurking" behind the dispute; (5) Cameron J observed that approaching sections 37 and 38 as creating separate powers would be "lopsided, limping and illogical" - they must be read together; (6) The minority judgment (Jafta J) emphasized the importance of judicial precedent and stare decisis, warning against departures from this Court's own decisions unless clearly wrong, and noted past failures to adhere to this principle; (7) Mojapelo AJ observed that Genesis appeared to have "deliberately submitted non-compliant annual financial statements so as to engineer a pure legal question" and that an insolvency case where members' rights are directly at issue would be a better occasion to reconsider member protections.
This judgment is significant in South African law for several reasons: (1) It clarifies the legal nature of PMSA funds held by medical schemes - they are assets of the scheme, not trust property held for members; (2) It establishes important principles about the commercial nature of the relationship between medical schemes and their members; (3) It provides guidance on the interplay between the Medical Schemes Act and the Financial Institutions (Protection of Funds) Act; (4) It clarifies when administrative instruments (like circulars) fall away when their legal foundation is removed, without needing separate setting aside; (5) It demonstrates the integrated interpretation of sections 35, 37 and 38 of the Medical Schemes Act; (6) It has implications for medical scheme insolvency - PMSA funds would now form part of the insolvent estate (though this was not directly at issue); (7) It addresses the standard for proving material influence of an error of law under PAJA section 6(2)(d); (8) The split decision (8-3) reflects the complexity of balancing statutory interpretation, commercial reality, member protection, and administrative law principles. The case overrules a longstanding High Court precedent (Omnihealth) that had governed the industry for several years and to which the sector had adjusted its practices.
Explore 7 related cases • Click to navigate